Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, November 03, 2023
Rentschler Biopharma SE, a contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, has announced the promotion of Dr. Björn Beckmann to the position of Head of Quality Control at the Company's Laupheim site in ...
read more
Monday, November 06, 2023
TC BioPharm, a clinical-stage biotechnology company focused on developing allogeneic gamma-delta T cell therapies for cancer, has chosen Fortrea as its Contract Research Organization (CRO) for conducting global trials, including ACHIEVE and ACHIEVE2,...
read more
Monday, November 06, 2023
Sygnature Discovery has incorporated an Azenta compound management storage system into its capabilities, enabling the storage of customer libraries as well. High-fidelity hit finding is a crucial initial step in successful drug discovery projects, ...
read more
Tuesday, November 07, 2023
Everest Clinical Research, a comprehensive contract research organization (CRO), has announced its acquisition of August Research. Everest, backed by Arlington Capital Partners, a private equity firm based in Washington, D.C. specializing in ...
read more
Tuesday, November 07, 2023
Discovery Life Sciences announced the appointment of Greg Herrema as its new chief executive officer. A leader with more than 20 years of experience across the life sciences and industrial sectors, Mr. Herrema will spearhead the next phase of ...
read more
Wednesday, November 08, 2023
Phesi, a leading provider of patient-centered data analytics, has enhanced its Trial Accelerator™ platform by introducing the Patient Access Score (PAS). This addition empowers clinical trial sponsors to pinpoint the most effective investigators.
read more
Wednesday, November 08, 2023
limentiv Inc., AcelaBio Inc., and PharmaNest Inc. announced their collaborative effort aimed at revolutionizing precision medicine and artificial intelligence (AI)-enabled digital pathology solutions for metabolic dysfunction-associated ...
read more
Thursday, November 09, 2023
Alloy Therapeutics, Inc., a biotechnology ecosystem company and Wheeler Bio, Inc., an agile contract development and manufacturing organization (CDMO), announced the formation of a non-exclusive, preferred service offering to drive translation from ...
read more
Thursday, November 09, 2023
Andelyn Biosciences, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), is collaborating with The Ohio State University Gene Therapy Institute for the development and clinical manufacturing of novel gene ...
read more
Thursday, November 09, 2023
Vetter has been granted a permanent Manufacturer’s Authorization for its clinical development facility located in Rankweil, Austria. This site has been in operation for nearly two years, and the Austrian Agency for Health and Food Safety (AGES), the ...
read more
Tuesday, November 14, 2023
ValGenesis, Inc., and Soluciones GXP have partnered to introduce the ValGenesis VLMS product suite alongside Soluciones GXP's immense regulatory expertise across the life sciences sector in Latin America (LATAM).
Uruguay-based Soluciones GXP ...
read more
Wednesday, November 15, 2023
ValGenesis, Inc., and Soluciones GXP have joined forces to introduce the ValGenesis VLMS product suite, leveraging Soluciones GXP's extensive regulatory expertise in the life sciences sector across Latin America (LATAM).
read more
Wednesday, November 15, 2023
Prange Group and its affiliate, Adragos Pharma, have officially entered into definitive agreements with Fresenius Kabi for the acquisition of the premier sterile pharmaceutical production facility located in Halden, Norway.
read more
Wednesday, November 15, 2023
Charles River Laboratories International, Inc. and Aitia, a pioneer in Causal AI and Digital Twins, have entered into a strategic agreement, granting Aitia access to Logica™—Charles River's Artificial Intelligence (AI)-powered drug solution platform....
read more
Thursday, November 16, 2023
Cryoport, Inc., a global leader in catering to the rapidly expanding cell and gene therapy sector, has revealed the augmentation of its worldwide supply chain network through the acquisition of Bluebird Express, LLC. Bluebird Express, a proficient ...
read more